Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03562455 · ClinicalTrials.gov registry record · NA
Virtual Reality for Power Wheelchair Training
A NA study of Spinal Diseases, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03562455: Completed NA study of Spinal Diseases, sponsored by University of Pittsburgh.
NCT03562455 is a NA study of Spinal Diseases that has completed, run by University of Pittsburgh. The registered enrollment target is 12 participants, below the 43,694-participant average among 4 other Spinal Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03562455, a NA study of Spinal Diseases, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the impact of VRSim 3.0 on power wheelchair (PWC) driving skills and to obtain qualitative feedback from users on the design of the virtual reality (VR) simulator to inform device development.
Primary Outcome
Power wheelchair driving skills will be evaluated using the Power Mobility Clinical Driving Assessment (PMCDA). The PMCDA contains 23 questions related to specific power wheelchair driving tasks. Each task will be given a score from 1 to 3; a score of 1 will be given if the driver requires physical assistance or cannot complete the task, a score of 2 will be given if the driver requires verbal or auditory hints or cues, but no physical assistance, and a score of 3 will be given if the driver com
Conditions Studied
Interventions
- OTHER VRSim 3.0
- BEHAVIORAL In-Person Wheelchair Training
Study Locations (1)
Pennsylvania
- Human Engineering Research Laboratories - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-06-19 |
| Est. Completion | 2019-08-02 |
| Phase | NA |
What the finished NCT03562455 record still lists
NCT03562455 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 43,694-participant average among 4 other Spinal Diseases trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Spinal Diseases appearing as the primary indexed condition, and to 2 interventions - of which VRSim 3.0 is the first listed.
NCT03562455 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03562455 about?
NCT03562455 is a clinical study titled "Virtual Reality for Power Wheelchair Training". The objective of this study is to evaluate the impact of VRSim 3.0 on power wheelchair (PWC) driving skills and to obtain qualitative feedback from users on the design of the virtual reality (VR) simulator to inform device development.
What is the current status of trial NCT03562455?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-06-19. Estimated completion is 2019-08-02.
What conditions does trial NCT03562455 study?
This clinical trial studies the following conditions: Spinal Diseases.
What interventions are being tested in trial NCT03562455?
The interventions under investigation include: VRSim 3.0 (OTHER), In-Person Wheelchair Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03562455?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03562455 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI